BATONI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 12.057
AS - Asia 5.999
EU - Europa 4.882
SA - Sud America 841
Continente sconosciuto - Info sul continente non disponibili 380
AF - Africa 276
OC - Oceania 11
Totale 24.446
Nazione #
US - Stati Uniti d'America 11.724
SG - Singapore 1.978
CN - Cina 1.775
IT - Italia 1.535
SE - Svezia 826
HK - Hong Kong 730
BR - Brasile 701
DE - Germania 575
VN - Vietnam 493
BG - Bulgaria 314
GB - Regno Unito 287
TR - Turchia 253
FR - Francia 236
FI - Finlandia 227
CA - Canada 219
KR - Corea 185
RU - Federazione Russa 182
IN - India 166
UA - Ucraina 152
AT - Austria 115
IE - Irlanda 114
JP - Giappone 95
NL - Olanda 84
SN - Senegal 76
CH - Svizzera 72
CI - Costa d'Avorio 59
MX - Messico 51
AR - Argentina 48
BD - Bangladesh 43
BE - Belgio 42
IQ - Iraq 40
PL - Polonia 34
ID - Indonesia 33
PK - Pakistan 26
ZA - Sudafrica 26
ES - Italia 22
SA - Arabia Saudita 22
EC - Ecuador 21
EG - Egitto 19
UZ - Uzbekistan 19
NG - Nigeria 18
VE - Venezuela 18
MA - Marocco 17
PH - Filippine 17
CO - Colombia 16
NP - Nepal 14
CZ - Repubblica Ceca 13
KE - Kenya 13
AE - Emirati Arabi Uniti 12
AL - Albania 12
DZ - Algeria 12
BB - Barbados 11
CL - Cile 11
PE - Perù 11
JO - Giordania 10
MY - Malesia 10
TH - Thailandia 10
TW - Taiwan 10
ET - Etiopia 9
KZ - Kazakistan 9
AU - Australia 8
JM - Giamaica 8
IL - Israele 7
OM - Oman 7
TT - Trinidad e Tobago 7
DO - Repubblica Dominicana 6
AZ - Azerbaigian 5
BJ - Benin 5
CR - Costa Rica 5
GT - Guatemala 5
PA - Panama 5
PY - Paraguay 5
UY - Uruguay 5
BO - Bolivia 4
DK - Danimarca 4
GA - Gabon 4
LT - Lituania 4
MD - Moldavia 4
PT - Portogallo 4
QA - Qatar 4
AM - Armenia 3
BY - Bielorussia 3
CG - Congo 3
GR - Grecia 3
HN - Honduras 3
IR - Iran 3
LB - Libano 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RO - Romania 3
SV - El Salvador 3
TN - Tunisia 3
BH - Bahrain 2
BS - Bahamas 2
CY - Cipro 2
EU - Europa 2
KG - Kirghizistan 2
NI - Nicaragua 2
Totale 24.032
Città #
Woodbridge 1.311
Ashburn 1.178
Singapore 1.070
Ann Arbor 883
Santa Clara 724
Hong Kong 717
Fairfield 686
Houston 666
San Jose 654
Chandler 635
Dallas 571
Shanghai 346
Beijing 343
Sofia 310
Seattle 281
Serra 264
Wilmington 264
Hefei 261
Cambridge 246
New York 244
Milan 209
Los Angeles 188
Seoul 179
Izmir 170
Jacksonville 169
Ottawa 162
Boardman 159
Princeton 145
Lawrence 124
Ho Chi Minh City 121
Council Bluffs 120
Lauterbourg 118
Pisa 115
Medford 106
Florence 99
Dublin 96
Nanjing 95
Bremen 94
Vienna 91
Munich 87
Tokyo 85
Des Moines 83
Dakar 76
Hanoi 75
Helsinki 70
Frankfurt am Main 69
London 64
Chicago 63
Istanbul 63
Dong Ket 61
Abidjan 59
Bern 56
Buffalo 56
Dearborn 55
Nanchang 49
Redondo Beach 47
Columbus 43
São Paulo 43
The Dalles 42
San Diego 41
Brussels 38
Orem 36
Lancaster 35
Falls Church 34
Livorno 33
Pune 33
Rome 32
Kunming 31
Somma Lombardo 31
Fuzhou 29
Turku 29
Jüchen 27
Quanzhou 27
Porto Alegre 26
Boulder 25
Ogden 24
Redwood City 24
Guangzhou 23
Phoenix 23
Lucca 22
Changsha 21
Manchester 21
Nuremberg 21
Atlanta 20
Baltimore 20
Haiphong 20
Warsaw 20
Belo Horizonte 19
Da Nang 19
Marseille 19
Philadelphia 19
Curitiba 18
Tashkent 18
Tianjin 18
Jakarta 17
Rio de Janeiro 17
Shenyang 17
Toronto 17
Chennai 16
Denver 16
Totale 16.456
Nome #
Insights into the Antimicrobial Properties of Hepcidins: Advantages and Drawbacks as Potential Therapeutic Agents 411
Biofilm growth on orthopedic implantable materials: static or dynamic condition what is the most appropriate methodological tools to study device-related infections? 383
The ESX-5 Associated eccB-eccC Locus Is Essential for Mycobacterium tuberculosis Viability 289
Chitosan nanoparticles for the linear release of model cationic peptide 278
Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein 272
T and B immunogenicity of SA5K a secretion antigen of Mycobacterium tuberculosis, in healthy subjects and in tuberculosis patients 244
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 232
COMPLETE RELEASE OF ADENOSINE-DEAMINASE FROM MOUSE LYMPHOCYTES STABILIZED BY LOW-PH ACETATE 231
Human CD56bright and CD56dim Natural Killer Cell Subsets Respond Differentially to Direct Stimulation with Mycobacterium bovis Bacillus Calmette-Guérin 227
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. 224
Detection of Biofilms in Biopsies from Chronic Rhinosinusitis Patients: In Vitro Biofilm Forming Ability and Antimicrobial Susceptibility Testing in Biofilm Mode of Growth of Isolated Bacteria 217
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 213
Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3 208
Anti-biofilm properties of the antimicrobial peptide temporin 1Tb and its ability, in combination with EDTA, to eradicate Staphylococcus epidermidis biofilms on silicone catheters 207
Influence of culture medium on the resistance and response of Mycobacterium bovis BCG to reactive nitrogen intermediates 206
Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis 205
Antibacterial, Antibiofilm, and Antiadhesive Properties of Different Quaternized Chitosan Derivatives 204
QUESTIONING THE ROLE OF ADENOSINE-DEAMINASE IN THE DEVELOPMENT OF LYMPHOCYTE-B IN CHICKEN BURSA 200
A comparison of various EIA plates for the analysis of poly-saccharide antigens and serological identification of Oral Streptococchi. New perspective on streptococci and streptococcal infections 200
Modelli dinamici nello studio del biofilm sui materiali protesici 200
Ulvan as novel reducing and stabilizing agent from renewable algal biomass: Application to green synthesis of silver nanoparticles 198
PURINE METABOLISM AND B-LYMPHOCYTE DEVELOPMENT IN THE CHICKEN BURSA OF FABRICIUS 196
Antifouling Properties of Electrospun Polymeric Coatings Induced by Controlled Surface Morphology 196
Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guérin in human macrophages and in mice 193
Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH 192
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients 191
Involvement of the Mycobacterium tuberculosis secreted antigen SA-5K in intracellular survival of recombinant Mycobacterium smegmatis 190
Purification, biochemical characterization and immunogenicity of SA5K, a secretion antigen of Mycobacterium tuberculosis 189
In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia 187
Integrated three-dimensional fiber/hydrogel biphasic scaffolds for periodontal bone tissue engineering 187
Innovative Biobased and Sustainable Polymer Packaging Solutions for Extending Bread Shelf Life: A Review 186
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 186
Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guerin (BCG) 186
Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates 183
Monoclonal antibodies specific for a polysaccharide antigenic determinant of Streptococcus mutans (serotypes c,e,f) 182
Identification and molecular cloning of a novel secretion antigen from Mycobacterium tuberculosis and Mycobacterium bovis BCG. 182
Generation of persister cells of Pseudomonas aeruginosa and Staphylococcus aureus by chemical treatment and evaluation of their susceptibility to membrane-targeting agents 182
Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide 181
Lymphocytic purine metabolic disorders in tubercolin anergic mice 180
Miocardiopatie dilatative e miocarditi: eziopatogenesi virale 180
Comparative analysis of bactericidal activity of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains 180
Antimicrobial peptides: promising molecules for the treatment of biofilm-associated infections. 180
The semi-synthetic peptide Lin-SB056-1 in combination with EDTA exerts strong antimicrobial and antibiofilm activity against pseudomonas aeruginosa in conditions mimicking cystic fibrosis sputum 178
EFFECT OF REMOVABLE ORTHODONTIC APPLIANCES ON ORAL COLONISATION BY MUTANS STREPTOCOCCI IN CHILDREN 177
Surface acoustic wave-based lab-on-a-chip for the fast detection of Legionella pneumophila in water 175
Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria 174
Antivirulence properties of a low-molecular-weight quaternized chitosan derivative against pseudomonas aeruginosa 174
Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium 173
In vitro Interaction of Pseudomonas aeruginosa Biofilms With Human Peripheral Blood Mononuclear Cells 173
Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Pseudomonas aeruginosa under Conditions Relevant to Cystic Fibrosis 170
Human gamma-delta+ T cell responses to mycobacterial soluble extracts 169
Microbiologia del cavo orale 169
First characterization in Italy of clinical isolates of mutans streptococci by using specific monoclonal antibodies. 169
Targeting pseudomonas aeruginosa in the sputum of primary ciliary dyskinesia patients with a combinatorial strategy having antibacterial and anti-virulence potential 169
Clonaggio molecolare di un nuovo antigene di secrezione di Mycobacterium tuberculosis e Mycobacterium bovis BCG 168
Allestimento di un saggio di RT-PCR per la valutazione dell'espressione di proteine micobatteriche in campioni di espettorato 168
Identification of a novel Mycobacterium bovis BCG secretion protein 166
Comparative analysis of subcellular distribution of protein antigens in Mycobacterium bovis Bacillus Calmette-Guerin 166
Expression of SA5K, a secretion antigen of Mycobacterium tuberculosis, inside human macrophages and in sputum from tuberculosis patients 166
Lactobacillus Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of Pseudomonas aeruginosa from Cystic Fibrosis Lung 165
Streptococcus mutans has a polysaccharide antigenic determinant in common with Streptococcus porcinus 164
BaAMPs: The database of biofilm-active antimicrobial peptides 163
Reduced human beta defensin 3 in individuals with periodontal disease 162
1ST CHARACTERIZATION IN ITALY OF CLINICAL ISOLATES OF MUTANS STREPTOCOCCI BY USING SPECIFIC MONOCLONAL-ANTIBODIES 161
Use of antimicrobial peptides against microbial biofilms: advantages and limits 161
Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria 161
The anti-microbial peptide (Lin-SB056-1)2-K reduces pro-inflammatory cytokine release through interaction with Pseudomonas aeruginosa lipopolysaccharide 161
Combination of two kinds of medicated microparticles based on hyaluronic acid or chitosan for a wound healing spray patch 161
Emerging Multiscale Biofabrication Approaches for Bacteriotherapy 160
Characterization of antigens recognized by new monoclonal antibodies raised against culture filtrate proteins of Mycobacterium bovis bacillus Calmette-Guerin 160
Functional characterization of human natural killer cells responding to Mycobacterium bovis bacillus Calmette-Guérin 159
Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-beta-defensin 3 and affect peptide's antibacterial activity in vitro 158
HIV-1 proviral DNA sequences in the saliva of patients with HIV infection. 157
Suscettibilità di batteri orali alla betadefensina umana 3, 157
Biopharmaceutical Assessment of Mesh Aerosolised Plasminogen, a Step towards ARDS Treatment 155
Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to Bactericidal Activity of Human beta-Defensin 3 in Biological Fluids 155
Human beta-defensin-3: a promising antimicrobial peptide 155
Perspectives on polymeric nanostructures for the therapeutic application of antimicrobial peptides 155
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 155
Alta frequenza di isolamento di Streptococcus Mutans in bambini privi di lesioni cariose e con patologie ortodontiche. 154
Incidence of mutans streptococci in insulin-dependent diabetes mellitus patients 153
Anti-A and anti-B hemagglutinin depletion during Cohn purification process of 5% immunoglobulin 152
Characterization of polysaccharide antigen of Streptococcus porcinus type II by monoclonal antibody 151
Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA. 150
In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains 150
Depression of the immune responsiveness in mice treated with thioacetamide after antigen exposure. 149
Effect of removable orthodontic appliances on oral colonisation by mutans streptococci in children 149
QSAR Model on Adenosine Derivatives as Antifungal Agents against Candida albicans: a Data Mining Approach 147
gamma-delta+ and CD4+alpha-beta+ human T cell subset responses upon stimulation with various Mycobacterium tuberculosis soluble extracts 147
Serological identification of mutans Streptococci using MAbs in comparison with biochemical and DNA-DNA hibridisation techniques 146
QSAR model on adenosine derivatives as antifungal agents against Candida albicans: a data mining approach 146
Identification of novel proteins in culture filtrates of Mycobacterium bovis bacillus Calmette-Guerin in the isoelectric point range 6-11 146
The secretion antigen SA5K has a role in the adaptation of Mycobacterium bovis bacillus Calmette-Guérin to intracellular stresses and hypoxia 146
Anti-Staphylococcal Biofilm Effects of a Liposome-Based Formulation Containing Citrus Polyphenols 145
Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells 145
Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria 144
Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections 144
Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option? 144
Use of a recombinant strain of Mycobacterium avium expressing beta-galactosidase to evaluate the activities of antimycobacterial agents inside macrophages 143
The activity of a Ga(III) catecholate complex against Aspergillus fumigatus in conditions mimicking cystic fibrosis lung and inhaled formulations for its pulmonary administration 142
Totale 18.140
Categoria #
all - tutte 67.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.471 0 82 27 107 245 230 42 74 77 43 102 442
2022/20232.161 271 287 167 261 176 286 21 169 346 10 121 46
2023/20241.595 171 108 223 65 165 273 59 153 77 66 77 158
2024/20255.236 69 199 65 334 543 569 453 242 571 659 620 912
2025/20266.147 480 667 744 456 643 531 971 375 425 470 211 174
2026/2027359 166 193 0 0 0 0 0 0 0 0 0 0
Totale 24.446